TLPH — TALPHERA, INC.

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1427925 ·
Last close
$0.80
Market Cap
$41.61M
52W High
$1.57
52W Low
$0.69
ADV30
137,168
Next earnings
2026-11-12
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate, Niyad, is a lyophilized formulation of nafamostat that acts as a regional anticoagulant for infusion into the extracorporeal circuit. It is also developing LTX-608, a lyophilized vial containing nafamostat for IV infusion for disseminated intravascular coagulation, acute respiratory distress syndrome, acute pancreatitis, and an anti-viral treatment; Fedsyra, an ephedrine pre-filled syringe for injection; and a phenylephrine pre-filled syringe for injection. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -3,924,000 -4,312,000 26,806,000 742,000 12,400,000
Mar 2026 0 — -3,948,000 -2,556,000 30,155,000 3,823,000 11,677,000
Dec 2025 0 — -3,453,000 -3,772,000 29,719,000 5,894,000 12,684,000
Sep 2025 1,000 — -3,422,000 -4,436,000 30,742,000 3,457,000 11,565,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-12,270,000
Investing CF
$-15,955,000
Financing CF
$22,176,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.27
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-478,388,000
Inventory
—
Receivables
—
ST Investments
$16,334,000
EBIT TTM
$-16,080,000
Pretax Income TTM
$-15,076,000
Interest Exp TTM
$0
Analysts
4

Yahoo Snapshot (yfinance, live)

Total Revenue
$1,000
EBITDA
—
Free Cash Flow
$-6,870,875
Enterprise Value
$43,145,500
Total Cash
$17,076,000
Total Debt
$6,499,000
Shares Out
51,957,714
Trailing EPS
$-0.26
Book Value
$0.34
ROE
-143.4%
ROA
-42.6%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 28,000 -13,484,000 -14,290,000 29,719,000 12,684,000 17,035,000 -11,364,000
Dec 2024 0 -15,252,000 -13,004,000 18,236,000 10,235,000 8,001,000 -12,683,000
Dec 2023 651,000 -16,889,000 -18,397,000 20,395,000 6,290,000 14,105,000 -17,492,000
Dec 2022 0 -20,352,000 47,755,000 47,487,000 25,673,000 21,814,000 -28,331,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$1,000
NetIncome TTM
$-15,076,000
OpCashFlow TTM
—
Assets (Latest)
$26,806,000
Forward EPS
$-0.22

Max Pain — expiry 2026-12-18

max pain strike: $1.00 · spot: $0.80 · call oi: 3,463 · put oi: 1,507
Expected Move to 2026-12-18: ±$0.25 (31.25%) — implied range $0.55 – $1.05 · ATM straddle on $1.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
ALDX Aldeyra Therapeutics, Inc. $41.88M $0.69 —
DWTX Dogwood Therapeutics, Inc. $41.29M $1.08 —
PLRX PLIANT THERAPEUTICS, INC. $40.93M $0.66 —
ATNM Actinium Pharmaceuticals, Inc. $42.45M $1.35 —
HYFT MindWalk Holdings Corp. $42.60M $0.91 —

News headlines (Yahoo Finance, 1h cache)

Talphera, Inc. Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
Talphera (TLPH) Q3 2026 Earnings Call Transcript
2026-11-13 06:15 · Yahoo
What Talphera (TLPH) Said on Its Q3 Earnings Call
2026-11-13 06:14 · Yahoo
Talphera: Q3 Earnings Snapshot
2026-11-12 21:07 · Yahoo
Talphera Reports Third Quarter 2026 Financial Results and Provides Business Update
2026-11-12 21:01 · Yahoo
Talphera to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
2026-11-04 13:30 · Yahoo
Talphera to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
2026-09-03 12:30 · Yahoo
Talphera (TLPH) Q2 2026 Earnings Call Transcript
2026-08-19 21:28 · Yahoo
Talphera Inc (TLPH) (Q2 2026) Earnings Call Highlights: NEPHRO Study Enrollment Hits 75% as ...
2026-08-13 05:03 · Yahoo
Talphera Q2 Earnings Call Highlights
2026-08-13 03:04 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.